欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0224/001
药品名称
Zipyran Plus
活性成分
pyrantel 50.0 mg
praziquantel 50.0 mg
febantel 150.0 mg
剂型
Tablet
上市许可持有人
Laboratorios Calier
参考成员国 - 产品名称
France (FR)
12986
互认成员国 - 产品名称
Greece (GR)
Bulgaria (BG)
许可日期
2011/05/18
最近更新日期
2020/10/16
药物ATC编码
QP52A ANTHELMINTICS
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
12986_D90_label_final
Date of last change:2024/09/06
Final PL
|
12986_D90_pl_final
Date of last change:2024/09/06
Final SPC
|
12986_D90_SPC_final
Date of last change:2024/09/06
Final Labelling
|
13573_D90_label_final
Date of last change:2024/09/06
Final PL
|
13573_D90_pl_final
Date of last change:2024/09/06
Final SPC
|
13573_D90_SPC_final
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase